Phase 3 randomized study of cabozantinib (XL184) versus everolimus in subjects with clear cell renal cell carcinoma (METEOR) Meeting Abstract
| Authors: | Choueiri, T. K.; Escudier, B. J.; Les, T. P.; Cella, D.; Ru, Q. C.; Scheffold, C.; Motzer, R. J. |
| Abstract Title: | Phase 3 randomized study of cabozantinib (XL184) versus everolimus in subjects with clear cell renal cell carcinoma (METEOR) |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613202125 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.tps4601 |
| Notes: | Meeting Abstract: TPS4601 -- Source: Wos |
